Humanized monoclonal antibodies against activated protein c and uses thereof
USRE49099E1 · kind E1 · reissue
0Cited by
9References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2019 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | May 22, 2039 |
Classification
- Technology area (CPC —)General
Abstract
Provided are humanized antibodies that selectively bind to and inhibit activated protein C without binding to or inhibiting unactivated protein C. Methods of treatment employing these antibodies are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.